TrialPLoS pathogens2022

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.

Xiao L Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.